{"entity":{"type":"insider","cik":"0001693805","url":"/insider/0001693805","json_url":"/insider/0001693805.json","name":"Keson-Brookes Maiken","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":8,"n_filings":7,"first":"2021-03-15","last":"2025-07-23","span_basis":"filed_date"},"name_variants":[{"name":"Keson-Brookes Maiken","source":"filing","n_filings":7,"first_seen":"2021-03-15","last_seen":"2025-07-23"}],"transactions":[{"id":4063188,"accession":"0000950170-25-097949","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000950170-25-097949","line_url":"/filing/0000950170-25-097949#line-1","is_derivative":false,"issuer_cik":"0001693805","issuer_name":"Mural Oncology plc","issuer_ticker":"MURA","issuer_name_source":null,"issuer_url":"/issuer/0001693805","owner_cik":"0001693805","owner_name":"Keson-Brookes Maiken","owner_display_name":"Keson-Brookes Maiken","owner_url":"/insider/0001693805","role":"Officer","role_mark":"O","role_mark_label":"Officer","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"See Remarks","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2572.0,"shares_display":"2,572","price_per_share":2.48,"price_display":"2.48","price_state":"stated","total_value":6378.56,"total_display":"6,378.56","total_whole":"6,379","shares_owned_after":68834.0,"shares_owned_after_display":"68,834","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-07-22","filed_date":"2025-07-23","scope":"insider"},{"id":4463009,"accession":"0000950170-25-097599","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000950170-25-097599","line_url":"/filing/0000950170-25-097599#line-1","is_derivative":false,"issuer_cik":"0001693805","issuer_name":"Mural Oncology plc","issuer_ticker":"MURA","issuer_name_source":null,"issuer_url":"/issuer/0001693805","owner_cik":"0001693805","owner_name":"Keson-Brookes Maiken","owner_display_name":"Keson-Brookes Maiken","owner_url":"/insider/0001693805","role":"Officer","role_mark":"O","role_mark_label":"Officer","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"See Remarks","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2158.0,"shares_display":"2,158","price_per_share":2.48,"price_display":"2.48","price_state":"stated","total_value":5351.84,"total_display":"5,351.84","total_whole":"5,352","shares_owned_after":71406.0,"shares_owned_after_display":"71,406","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-07-18","filed_date":"2025-07-22","scope":"insider"},{"id":4712140,"accession":"0000950170-25-033769","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000950170-25-033769","line_url":"/filing/0000950170-25-033769#line-3","is_derivative":false,"issuer_cik":"0001693805","issuer_name":"Mural Oncology plc","issuer_ticker":"MURA","issuer_name_source":null,"issuer_url":"/issuer/0001693805","owner_cik":"0001693805","owner_name":"Keson-Brookes Maiken","owner_display_name":"Keson-Brookes Maiken","owner_url":"/insider/0001693805","role":"Officer","role_mark":"O","role_mark_label":"Officer","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"See Remarks","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1469.0,"shares_display":"1,469","price_per_share":3.45,"price_display":"3.45","price_state":"stated","total_value":5068.05,"total_display":"5,068.05","total_whole":"5,068","shares_owned_after":73564.0,"shares_owned_after_display":"73,564","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-03-05","filed_date":"2025-03-05","scope":"insider"},{"id":4712131,"accession":"0000950170-25-033769","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000950170-25-033769","line_url":"/filing/0000950170-25-033769#line-2","is_derivative":false,"issuer_cik":"0001693805","issuer_name":"Mural Oncology plc","issuer_ticker":"MURA","issuer_name_source":null,"issuer_url":"/issuer/0001693805","owner_cik":"0001693805","owner_name":"Keson-Brookes Maiken","owner_display_name":"Keson-Brookes Maiken","owner_url":"/insider/0001693805","role":"Officer","role_mark":"O","role_mark_label":"Officer","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"See Remarks","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1262.0,"shares_display":"1,262","price_per_share":3.36,"price_display":"3.36","price_state":"stated","total_value":4240.32,"total_display":"4,240.32","total_whole":"4,240","shares_owned_after":75033.0,"shares_owned_after_display":"75,033","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-03-04","filed_date":"2025-03-05","scope":"insider"},{"id":3265159,"accession":"0000950170-24-140393","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000950170-24-140393","line_url":"/filing/0000950170-24-140393#line-1","is_derivative":false,"issuer_cik":"0001693805","issuer_name":"Mural Oncology plc","issuer_ticker":"MURA","issuer_name_source":null,"issuer_url":"/issuer/0001693805","owner_cik":"0001693805","owner_name":"Keson-Brookes Maiken","owner_display_name":"Keson-Brookes Maiken","owner_url":"/insider/0001693805","role":"Officer","role_mark":"O","role_mark_label":"Officer","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"See Remarks","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2555.0,"shares_display":"2,555","price_per_share":3.27,"price_display":"3.27","price_state":"stated","total_value":8354.85,"total_display":"8,354.85","total_whole":"8,355","shares_owned_after":41295.0,"shares_owned_after_display":"41,295","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-12-23","filed_date":"2024-12-26","scope":"insider"},{"id":2461362,"accession":"0000950170-24-084569","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000950170-24-084569","line_url":"/filing/0000950170-24-084569#line-1","is_derivative":false,"issuer_cik":"0001693805","issuer_name":"Mural Oncology plc","issuer_ticker":"MURA","issuer_name_source":null,"issuer_url":"/issuer/0001693805","owner_cik":"0001693805","owner_name":"Keson-Brookes Maiken","owner_display_name":"Keson-Brookes Maiken","owner_url":"/insider/0001693805","role":"Officer","role_mark":"O","role_mark_label":"Officer","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"See Remarks","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2157.0,"shares_display":"2,157","price_per_share":3.41,"price_display":"3.41","price_state":"stated","total_value":7355.37,"total_display":"7,355.37","total_whole":"7,355","shares_owned_after":43850.0,"shares_owned_after_display":"43,850","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-07-18","filed_date":"2024-07-18","scope":"insider"},{"id":6386992,"accession":"0001179110-22-000694","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001179110-22-000694","line_url":"/filing/0001179110-22-000694#line-2","is_derivative":false,"issuer_cik":"0001693805","issuer_name":"Rubius Therapeutics, Inc.","issuer_ticker":"RUBY","issuer_name_source":null,"issuer_url":"/issuer/0001693805","owner_cik":"0001693805","owner_name":"Keson-Brookes Maiken","owner_display_name":"Keson-Brookes Maiken","owner_url":"/insider/0001693805","role":"Officer (CLO & Corp. Secretary)","role_mark":"O","role_mark_label":"Officer (CLO & Corp. Secretary)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CLO & Corp. Secretary","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2732.0,"shares_display":"2,732","price_per_share":6.573,"price_display":"6.57","price_state":"stated","total_value":17957.436,"total_display":"17,957.44","total_whole":"17,957","shares_owned_after":5343.0,"shares_owned_after_display":"5,343","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-02-01","filed_date":"2022-02-01","scope":"insider"},{"id":4465868,"accession":"0001179110-21-003441","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001179110-21-003441","line_url":"/filing/0001179110-21-003441#line-2","is_derivative":false,"issuer_cik":"0001693805","issuer_name":"Rubius Therapeutics, Inc.","issuer_ticker":"RUBY","issuer_name_source":null,"issuer_url":"/issuer/0001693805","owner_cik":"0001693805","owner_name":"Keson-Brookes Maiken","owner_display_name":"Keson-Brookes Maiken","owner_url":"/insider/0001693805","role":"Officer (CLO & Corp. Secretary)","role_mark":"O","role_mark_label":"Officer (CLO & Corp. Secretary)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CLO & Corp. Secretary","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":25000.0,"shares_display":"25,000","price_per_share":20.2386,"price_display":"20.24","price_state":"stated","total_value":505965.0,"total_display":"505,965.00","total_whole":"505,965","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-03-15","filed_date":"2021-03-15","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":8,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":8,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":8},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001971543","name":"Mural Oncology plc","url":"/issuer/0001971543","role":"Officer","n_filings":5,"first_seen":"2024-07-18","last_seen":"2025-07-23"},{"type":"issuer","type_label":"ISSUER","cik":"0001709401","name":"Rubius Therapeutics, Inc.","url":"/issuer/0001709401","role":"Officer (CLO & Corp. Secretary)","n_filings":2,"first_seen":"2021-03-15","last_seen":"2022-02-01"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001693805","retrieved_at":"2026-08-24T09:48:10+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}